JUPITER ASSET MANAGEMENT LTD

Position in NVAX — Novavax Inc

CIK 1215838 London, X0

Position in NVAX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$10,081,585

+$9,099,659 QoQ

Shares Held

1,070,232

+632.4% QoQ

Ownership

0.649%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#21

of 263 holders

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JUPITER ASSET MANAGEMENT LTD holds $354,007,590 across 28 Biotechnology names. NVAX ranks #10 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	126,099	$78,627,770
2	INCY	Incyte Corp	511,050	$57,932,627
3	PTCT	Ptc Therapeutics, Inc.	707,450	$57,706,695
4	NTLA	Intellia Therapeutics, Inc.	1,849,507	$31,293,657
5	IOVA	Iovance Biotherapeutics, Inc.	4,535,080	$18,865,932
6	AUPH	Aurinia Pharmaceuticals Inc.	1,094,475	$18,573,240
7	BEAM	Beam Therapeutics Inc.	445,718	$15,297,041
8	RLAY	Relay Therapeutics, Inc.	719,576	$13,463,266

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,081,585	1,070,232	+632.4%	Shares	Sole	2026-08-10
2025-12-31	$981,926	146,120	+45.2%	Shares	Sole	2026-02-10
2025-09-30	$872,271	100,608	-88.6%	Shares	Sole	2025-11-10
2025-06-30	$5,546,583	880,410	+195.9%	Shares	Sole	2025-08-08
2025-03-31	$1,907,308	297,552	+711.5%	Shares	Sole	2025-05-09
2023-12-31	$176,001	36,667	0.0%	Shares	Defined	2024-02-09
2023-09-30	$265,469	36,667	0.0%	Shares	Defined	2023-11-09
2023-06-30	$272,435	36,667	0.0%	Shares	Defined	2023-08-10
2023-03-31	$254,102	36,667	0.0%	Shares	Defined	2023-05-10
2022-12-31	$376,936	36,667	—	Shares	Defined	2023-02-10
No filing history on record for this holder in this stock.